×
Choose Speciality

EXPLORE!

LOGIN

Meclizine Hydrochloride Tablets USP manufactured by Lupin receive USFDA approval

  532 Views

eMediNexus    13 August 2022

The United States Food and Drug Administration (FDA) has approved Lupin Limited′s Abbreviated New New Drug Application (ANDA) for Meclizine Hydrochloride Tablets USP.

The Lupin plant in Goa will be used to produce the Meclizine Hydrochloride Tablets, 12.5 mg, 25 mg, and 50 mg, which Casper Pharma LLC will market as a generic version of Antivert Tablets, 12.5 mg, 25 mg, and 50 mg.

In the US, it was predicted that Meclizine Hydrochloride Tablets (RLD Antivert) generated yearly sales of USD 29 million.  (ETHealthWorld, August 12, 2022)

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.